113 related articles for article (PubMed ID: 18246799)
1. [Expression of ezrin and CD44-v6 in human esophageal squamous cell carcinoma and its clinical significance].
Chai LX; Sun KL; Guo LP; Zhang HT; Lu SX
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):685-8. PubMed ID: 18246799
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of Ezrin and E-cadherin in esophageal squamous cell carcinoma.
Zhai JW; Yang XG; Yang FS; Hu JG; Hua WX
Chin J Cancer; 2010 Mar; 29(3):317-20. PubMed ID: 20193117
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the expression of adhesion molecules in primary esophageal squamous cell carcinoma and metastatic lymph nodes.
Takayama N; Arima S; Haraoka S; Kotho T; Futami K; Iwashita A
Anticancer Res; 2003; 23(6a):4435-42. PubMed ID: 14666731
[TBL] [Abstract][Full Text] [Related]
5. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis.
Akita H; Doki Y; Yano M; Miyata H; Miyashiro I; Ohigashi H; Ishikawa O; Nishiyama A; Imaoka S
Dis Esophagus; 2009; 22(4):291-7. PubMed ID: 19021686
[TBL] [Abstract][Full Text] [Related]
6. Independent histological risk factors for lymph node metastasis of superficial esophageal squamous cell carcinoma; implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection.
Chiba T; Kawachi H; Kawano T; Kumagai J; Kitagaki K; Sekine M; Uchida K; Kobayashi M; Sugihara K; Eishi Y
Dis Esophagus; 2010 Jul; 23(5):398-407. PubMed ID: 19903192
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of ezrin in esophageal squamous cell carcinoma.
Zeng H; Xu L; Xiao D; Zhang H; Wu X; Zheng R; Li Q; Niu Y; Shen Z; Li E
J Histochem Cytochem; 2006 Aug; 54(8):889-96. PubMed ID: 16585385
[TBL] [Abstract][Full Text] [Related]
8. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
[TBL] [Abstract][Full Text] [Related]
9. [Expression of CD44 standard and CD44 variant 6 in human lung cancer].
Ochiai S; Nakanishi Y; Mizuno K; Hashimoto S; Inutsuka S; Kawasaki M; Yatsunami J; Hara N
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1179-85. PubMed ID: 9493443
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of Ezrin and CD44 co‑expression in breast cancer.
Ma L; Jiang T
Oncol Rep; 2013 Oct; 30(4):1899-905. PubMed ID: 23900701
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of lymph node metastases in early esophageal carcinoma and treatment regimens].
Li L; Liu SY; Zhu KS; Chen JQ; Ying MG
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):226-9. PubMed ID: 19615267
[TBL] [Abstract][Full Text] [Related]
13. Ezrin Ser66 phosphorylation regulates invasion and metastasis of esophageal squamous cell carcinoma cells by mediating filopodia formation.
Li LY; Xie YH; Xie YM; Liao LD; Xu XE; Zhang Q; Zeng FM; Tao LH; Xie WM; Xie JJ; Xu LY; Li EM
Int J Biochem Cell Biol; 2017 Jul; 88():162-171. PubMed ID: 28504189
[TBL] [Abstract][Full Text] [Related]
14. [The expression and clinical significance of RhoA, Ezrin and CD44 in laryngeal squamous cell carcinoma].
Xie YX; Shang XL; Fan J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(3):191-194. PubMed ID: 29871220
[No Abstract] [Full Text] [Related]
15. Explore the radiotherapeutic clinical target volume delineation for thoracic esophageal squamous cell carcinoma from the pattern of lymphatic metastases.
Cheng J; Kong L; Huang W; Li B; Li H; Wang Z; Zhang J; Zhou T; Sun H
J Thorac Oncol; 2013 Mar; 8(3):359-65. PubMed ID: 23263689
[TBL] [Abstract][Full Text] [Related]
16. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological investigation of lymph node metastasis predictors in superficial esophageal squamous cell carcinoma with a focus on evaluation of lympho-vascular invasion.
Mitobe J; Ikegami M; Urashima M; Takahashi H; Goda K; Tajiri H
Scand J Gastroenterol; 2013 Oct; 48(10):1173-82. PubMed ID: 23971724
[TBL] [Abstract][Full Text] [Related]
19. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
[TBL] [Abstract][Full Text] [Related]
20. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
